biomedicina slovenica

pr=Čučnik : 201-300

  1. Kovačič J; Anderluh G; Božič B; Čučnik S; Derganc J; Majhenc J; Svetina S; Irman Š; Škarabot M; Muševič I
    In vitro models of aPL phospholipid membrane interactions-our experiences
    2010 ►
  2. Božič Borut; Čučnik Saša; Gašperšič Nataša; Ambrožič Aleš; Kveder Tanja; Rozman Blaž
    Rational laboratory diagnostics of antiphospholipid antibodies: anticardiolipin, anti-beta2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies
    2009 ►
  3. Avčin T; Benseler SM; Tyrell PN; Čučnik S; Silverman ED
    A follow-up study of aPL and associated neuropsychiatric manifestations in 137 children with SLE
    2007 ►
  4. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Avidity of anti-beta2 GPI antibodies in patients with antihospholipid syndrome
    2007 ►
  5. Lakota Katja; Thallinger Gerhard G; Čučnik Saša; Božič Borut; Mrak-Poljšak Katjuša; Ambrožič Aleš; Rozman Blaž; Blinc Aleš; Tomšič Matija; Sodin-Šemrl Snežna
    Could antibodies against serum amyloid a function as physiological regulators in humans?
    2010 ►
  6. Kovačič Jasna; Božič Borut; Čučnik Saša; Rozman Blaž; Svetina Saša
    Binding properties of beta2-glycoprotein I
    2010 ►
  7. Žager Urška; Lunder Mojca; Čučnik Saša; Štrukelj Borut; Kveder Tanja; Rozman Blaž; Božič Borut
    Putative paratope-mimicking peptide of anti-B2GPI antibodies revealed by phage display
    2010 ►
  8. Žigon Polona; Ambrožič Aleš; Čučnik Saša; Sodin-Šemrl Snežna; Božič Borut; Kveder Tanja; Rozman Blaž
    Low avidity antiprothrombin antibodies are detected solely by aps/pt elisa in patients with antiphospholipid syndrome
    2010 ►
  9. Holc Iztok; Hojs Radovan; Čikeš Nada; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž; Pahor Artur
    Atherosclerosis and antiphospholipid antibodies: insights from rheumatoid arthritis - a five year follow up study
    2010 ►
  10. Ambrožič A; Boc A; Čučnik S; Mavri A; Žigon P; Štalc M; Kveder T; Vene N
    Optimal time frame ACL and anti-beta2GPI testing in patients with new diagnosed deep venous thrombosis
    2010 ►
  11. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Oxidation of immunoglobulins class G - a possible mechanism to provoke their autoimmune activity
    2008 ►
  12. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Oxidised immunoglobulins express autoimmune and pro-inflammatory activity
    2009 ►
  13. Jurgec I; Lunder M; Bratkovič T; Čučnik S; Kveder T; Rozman B; Božič B
    Hydrogen bonds are crucial for the anti-beta 2-glycoprotein I antibody bindings to the antigen
    2009 ►
  14. Lakota Katja; Čučnik Saša; Žigon Polona; Kveder Tanja; Tomšič Matija; Rozman Blaž; Božič Borut; Sodin-Šemrl Snežna
    Serum amyloid A - protein and its autoantibody levels compared in different diagnoses
    2008 ►
  15. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Binding of high and low avidity antibodies to beta 2-glycoprotein I in fluid phase
    2008 ►
  16. Toplak N; Kveder T; Trampuš-Bakija A; Šubelj V; Čučnik S; Avčin T
    Autoimmune response following annual influenza vaccination in 92 apparently healthy adults
    2008 ►
  17. Sodin-Šemrl Snežna; Frank Mojca; Ambrožič Aleš; Pavlič Janez; Šuštar Vid; Čučnik Saša; Božič Borut; Kveder Tanja; Rozman Blaž
    Interactions of phospholipid binding proteins with negatively charged membranes: beta2-glycoprotein I as a model mechanism
    2008 ►
  18. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Autoimmune and proinflammatory activity of oxidized immunoglobulins
    2008 ►
  19. Avčin T; Benseler SM; Tyrell PN; Čučnik S; Silverman ED
    Longitudinal follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2007 ►
  20. Čučnik S; Kveder T; Rozman B; Božič B
    Differences in antigen binding of high and low avidity anti beta-glycoprotein I antibodies
    2007 ►
  21. Božič B; Čučnik S; Kveder T; Rozman B
    Changes in specificity of common IgG during electrooxidation
    2007 ►
  22. Lakota K; Čučnik S; Žigon P; Kveder T; Tomšič M; Rozman B; Sodin-Šemrl S
    Levels of serum amyloid A and its autoantibodies in autoimmune diseases with and/or without thrombosis
    2008 ►
  23. Avčin T; Benseler SM; Tyrrell PN; Čučnik S; Silverman ED
    A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2008 ►
  24. Frank Mojca; Manček-Keber Mateja; Čučnik Saša; Kandušer Maša; Rozman Blaž; Jerala Roman; Iglič Aleš; Kralj-Iglič Veronika
    Number of microvesicles isolated from human plasma correlates with the ability of human plasma to mediate attractive interaction between phospholipid bilayers
    2007 ►
  25. Lokar M; Frank M; Čučnik S; Urbanija J; Iglič A; Kralj-Iglič V; Rozman B
    Antagonist effect of antiphospholipid antibodies and beta-2 glycoprotein I on budding phospholipid vesicles
    2007 ►
  26. Rozman B; Čučnik S; Sodin-Šemrl S; Czirjak L; Varju C; Distler O; Huscher D; Aringer M; Steiner G; Kveder T
    Prevalence and clinical associations of anti-KU antibodies in patients with systemic sclerosis: a European EUSTAR - initiated multicentre case-control study
    2008 ►
  27. Urbanija Jasna; Rozman Blaž; Ambrožič Aleš; Čučnik Saša; Kandušer Maša; Iglič Aleš; Kralj-Iglič Veronika
    Interactions of antibodies and an antigen with giant phospholipid vesicles in a study of antiphospholipid syndrom
    2006 ►
  28. Urbanija Jasna; Tomšič Nejc; Lokar Maruša; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Kandušer Maša; Iglič Aleš; Kralj-Iglič Veronika
    Coalescence of phospholipid membranes as a possible origin of anticoagulant effect of serum proteins
    2007 ►
  29. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high avidity anti-beta-2glycoprotein I antibodies to the antigen in fluid phase
    2007 ►
  30. Salobir Barbara; Šabovič Mišo; Hojnik Maja; Čučnik Saša; Kveder Tanja
    Anti-beta2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease
    2007 ►
  31. Čučnik Saša; Kveder Tanja
    Metodološki problemi v serologiji avtoprotiteles (sistemsko vezivno tkivnih bolezni)
    2007 ►
  32. Ambrožič Aleš; Čučnik Saša; Tomšič Nejc; Urbanija Jasna; Lokar Maruša; Babnik Blaž; Rozman Blaž; Iglič Aleš; Kralj-Iglič Veronika
    Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies
    2006 ►
  33. Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Affinity and avidity of autoantibodies
    2007 ►
  34. Pahor Artur; Hojs Radovan; Holc Iztok; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis
    2006 ►
  35. Lukač Janja; Čučnik Saša; Kveder Tanja; Strle Franc; Rozman Blaž
    Anti-beta2-glycoprotein I antibodies in Lyme borreliosis: differences in disease stage and immunoglobulin class distribution
    2006 ►
  36. Sodin-Šemrl S; Žigon P; Čučnik S; Kveder T; Blinc A; Tomšič M; Rozman B
    Serum amyloid A in autoimmune thrombosis
    2006 ►
  37. Urbanija Jasna; Lokar Maruša; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Iglič Aleš; Kralj-Iglič Veronika
    Differences in the effect of antiphospholipid antibodies and beta2-glycoprotein-1 on the morphology of giant phospholipid vesicles
    2006 ►
  38. Tomšič Nejc; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Kralj-Iglič Veronika
    Stability and fragmentation of negatively charged and electrically neutral phospholipid membranes
    2006 ►
  39. Babnik Blaž; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Pernuš Franjo; Iglič Aleš; Sevšek France; Kralj-Iglič Veronika
    Analysis of shape fluctuations of giant phospholipid vesicles as a method for study the protein-lipid interactions in membranes
    2006 ►
  40. Božič B; Čučnik S; Kveder T; Rozman B
    Changes in avidity and specificity of IgG during electro-oxidation. Relevance of binding of anti-beta2-GPI antibodies
    2006 ►
  41. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high avidity anti-beta2-glycoprotein I antibodies does not depend on antigen density
    2006 ►
  42. Sodin-Šemrl S; Žigon P; Čučnik S; Kveder T; Blinc A
    Serum amyloid A in autoimmune thrombosis
    2006 ►
  43. Martinuč-Porobič J; Avčin T; Božič B; Kuhar M; Čučnik S; Zupančič M; Prosenc K; Kveder T; Rozman B
    Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
    2005 ►
  44. Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Avidity of anti-beta2-glycoprotein 1 antibodies in patients with antiphospholipid syndrome
    2005 ►
  45. Praprotnik Sonja; Čučnik Saša
    Pomen določitve protiteles proti cikličnemu citruliranemu peptidu - anti-CCP pri bolnikih z artritisom
    [The significance of anti-cyclic citrullinated antibodies - anti-CCP in patients with arthritis]
    2005 ►
  46. Čučnik S; Božič B; Kveder T; Tomšič M; Rozman B
    Avidity of anti-beta2-glycoprotein I and thrombosis or unsuccessful pregnancy in patients with antiphospholipid syndrome
    2005 ►
  47. Čučnik S; Božič B; Kveder T; Tomšič M; Rozman B
    Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome
    2005 ►
  48. Božič B; Čučnik S; Kveder T; Rozman B
    Avidity of anti-beta-2-glycoprotein I antibodies
    2005 ►
  49. Žigon P; Božič B; Čučnik S; Rozman B; Tomšič M; Kveder T
    Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjoegren's syndrome?
    2005 ►
  50. Rozman B; Ambrožič A; Čučnik S; Avčin T; Božič B; Kveder T
    Heterogenost avtoprotiteles proti beta2-glikoproteinu 1
    [Heterogeneity of antibodies against beta2-glycoprotein 1]
    2005 ►
  51. Žigon Polona; Hočevar Alojzija; Čučnik Saša; Božič Borut; Rozman Blaž; Tomšič Matija; Kveder Tanja
    Protitelesa proti 25 aminokislin dolgemu sintetičnemu peptidu acetilholinskega muskarinskega receptorja
    [Antibodies against 25-mer synthetic pepetide of m3 muscarinic acetylcholine receptor]
    2004 ►
  52. Čučnik S; Kveder T; Rozman B; Božič B
    The recognition of beta2GPI by polyclonal anti-beta2GPI antibodies
    2004 ►
  53. Čučnik S; Kveder T; Križaj I; Rozman B; Božič B
    Anti-beta2-glycoprotein I antibodies' avidity
    2004 ►
  54. Božič B; Čučnik S; Kveder T; Rozman B
    Association of high avidity anti-beta2GPI antibodies with thrombosis in patients with APS
    2004 ►
  55. Avčin T; Martinuc J; Kuhar M; Božič B; Čučnik S; Zupančič M; Kveder T; Rozman B
    Antiphospholipid antibodies following vaccination with recombinant hepatitis B vaccine
    2004 ►
  56. Čučnik Saša; Kveder Tanja; Ambrožič Aleš; Božič Borut
    High avidity antibodies against beta2-glycoprotein I
    [Visoko avidna protitelesa proti beta2-glikoproteinu I]
    2004 ►
  57. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Isolation of beta2GPI by perchloric acid yields three protein peaks having different antigenic properties
    [Izolacija beta2GPI s perklorno kislino prinaša tri proteinske frakcije z različnimi antigenskimi lastnostmi]
    2004 ►
  58. Ambrožič Aleš; Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Prothrombin fragment 1+2 as a marker of hypercoagulable state in patients with antiphospholipid antibodies
    [Protrombinski fragment 1+2 kot označevalec hiperkoagulabilnega stanja pri bolnikih z antifosfolipidnimi protitelesi]
    2004 ►
  59. Čučnik Saša; Kveder Tanja; Božič Borut
    Paratope diversity of anti-prothrombin antibodies
    [Paratopska raznolikost protiteles proti protrombinu]
    2004 ►
  60. Božič Borut; Čučnik Saša; Ambrožič Aleš; Lestan Boris; Kos-Golja Mojca; Rozman Blaž; Kveder Tanja
    Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    [Klinilčna občutljivost protiteles proti cikličnem citruliniranem peptidu pri bolnikih z revmatoidnim artritisom]
    2004 ►
  61. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high-avidity anti-beta2-glycoprotein I antibodies
    2004 ►
  62. Čučnik S; Kveder T; Križaj I; Rozman B; Božič B
    High avidity anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    2004 ►
  63. Čučnik S; Božič B
    Antibodies to protein cofactors in APS
    2004 ►
  64. Božič Borut; Čučnik Saša; Ambrožič Aleš; Kveder Tanja; Rozman Blaž
    High avidity anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    2004 ►
  65. Čučnik S; Kveder Tanja; Rozman B; Božič Borut
    Heterogenous avidity of anti-beta2-glycoprotein I antibodies
    2004 ►
  66. Avčin T; Markelj G; Nikšič V; Rener-Primec Z; Čučnik S; Zupančič M; Rozman B; Neubauer D
    Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine
    2004 ►
  67. Čučnik Saša
    Pomen avidnosti protiteles proti beta2-glikoproteinu I pri bolnikih s sistemskimi avtoimunskimi boleznimi
    [The importance of anti-beta2-glycoprotein I antibodies' avidity in patients with systemic autoimmune diseases]
    2004 ►
  68. Čučnik S; Rozman B; Kveder T; Božič B
    Protein C inhibitor, isolated together with beta2-glycoprotein I (beta2GPI). A possible player in anti-beta2GPI antibody mediated thrombosis?
    2003 ►
  69. Salobir B; Šabovič M; Hojnik M; Čučnik S; Kveder T
    Antiphospholipid antibodies in young women without autoimmune diseases and suffering from arterial or venous thromboses
    2003 ►
  70. Čučnik Saša; Križaj Igor; Rozman Blaž; Kveder Tanja; Božič Borut
    Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I
    2004 ►
  71. Žigon P; Hočevar A; Čučnik S; Rozman B; Tomšič M; Kveder T
    Antibodies against 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor
    2004 ►
  72. Čučnik S; Gašperšič N; Kveder T; Božič B
    Concomitant appearance of anti-cardiolipin, anti-beta2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies
    2004 ►
  73. Ambrožič A; Božič B; Čučnik S; Rozman B
    Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
    2004 ►
  74. Gašperšič N; Rot U; Čučnik S; Božič B; Kveder T; Rozman B
    Low prevalence of antiphospholipid antibodies in a series of young patients with cerebrovascular disease
    2003 ►
  75. Čučnik Saša; Božič Borut
    Cerebrovascular manifestations in antiphospholipid syndrome
    2001 ►
  76. Božič B; Čučnik S; Ambrožič A; Kveder T
    Detection of antiprothrombin antibodies
    2003 ►
  77. Čučnik S; Križaj I; Rozman B; Kveder T; Božič B
    Isolation of beta2-glycoprotein I (beta2GPI) yields also protein C inhibitor - a possible player in anti-beta2GPI antibody mediated thrombosis
    2003 ►
  78. Čučnik S; Kveder T; Ambrožič A; Božič B
    High-affinity antibodies against beta2-glycoprotein I
    2003 ►
  79. Čučnik S; Kveder T; Božič B
    Paratope diversity of anti-prothrombin antibodies
    2003 ►
  80. Čučnik S; Gašperšič N; Rot U; Božič B; Kveder T
    Cerebrovascular insult and antiphospholipid antibodies in young adults
    2002 ►
  81. Gašperšič N; Čučnik S; Kveder T; Božič B
    Do IgA antiphospholipid antibodies have any clinical importance?
    2002 ►
  82. Božič B; Križaj J; Čučnik S; Hojnik M; Kveder T
    Long percholic acid precipitation in beta2-GPI isolation gives protein C inhibitor - a novel antigenic target in primary APS
    2002 ►
  83. Čučnik S; Ambrožič A; Avčin T; Koike T
    Heterogeneous behaviour of anti-beta2-glycoprotein I antibodies on diverse commercially available microtiter plates
    2002 ►
  84. Čučnik Saša; Kveder Tanja; Gašperšič Nataša; Božič Borut
    (Non)simultaneous appearance of anti-cardiolipin, anti-B2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies in patients with SLE and/or APS
    2002 ►
  85. Gašperšič N; Rot U; Čučnik S; Kveder T; Božič B; Rozman B
    Anti-annexin V antibodies in patients with cerebrovascular disease
    2003 ►
  86. Božič B; Čučnik S; Križaj I; Kveder T
    Protein C inhibitor, isolated together with beta2glycoprotein I, reacted with APS sera
    2002 ►
  87. Čučnik S; Kveder T; Božič B
    Heterogeneity of anti-prothrombin antibodies, detected by diferent ELISAs
    2002 ►
  88. Božič B; Čučnik S; Gašperšič N; Ambrožič A; Rozman B; Kveder T
    Antibodies against prothrombin and annexin V
    2002 ►
  89. Božič B; Gašperšič N; Čučnik S; Ambrožič A; Kveder T
    Anti-prothrombin and anti-annexin V antibodies
    2002 ►
  90. Rot U; Gašperšič N; Čučnik S; Božič B; Kveder T; Rozman B
    Antiphospholipid antibodies in young adults with neurological disorders
    2002 ►
  91. Božič B; Čučnik S; Ambrožič A; Lestan B; Kos-Golja M; Rozman B; Kveder T
    Antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    2002 ►
  92. Božič B; Čučnik S
    Cerebrovaskularne motnje v okviru antifosfolipidnega sindroma
    2001 ►
  93. Čučnik Saša; Božič Borut; Kveder Tanja; Rozman Blaž
    Antifosfolipidna protitelesa in možganska kap pri mladih ženskah brez sistemskih avtoimunskih bolezni
    2000 ►
  94. Čučnik Saša; Ambrožič Aleš; Kveder Tanja; Skitek Milan; Božič Borut
    Vrednotenje analizne metode s pomočjo biološke variabilnosti
    2000 ►
  95. Čučnik S; Kveder T; Hojnik M; Božič B
    Isolation of beta2GPI by perchloric acid yields three proteins having different antigenic properties
    2001 ►
  96. Božič B; Čučnik S; Ambrožič A; Lestan B; Kos-Golja M; Rozman B; Kveder T
    Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    2001 ►
  97. Čučnik Saša; Ambrožič Aleš; Božič Borut; Skitek Milan; Kveder Tanja
    Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards
    2000 ►
  98. Čučnik Saša; Božič Borut; Ambrožič Aleš; Skitek Milan; Kveder Tanja
    The evaluation of anti-beta2GP 1 ELISA by analytical goals based on biological variations
    2000 ►
  99. Čučnik Saša
    Antifosfolipidna protitelesa pri trombozi, aterosklerozi in hipertenziji
    2000 ►
  100. Čučnik S; Strokol H; Hojnik M; Kveder T; Božič B; Rozman B
    Association of aCL and anti-beta2GPI with hypertension
    1998 ►

   1 101 201 301 

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics